About this Journal Submit a Manuscript Table of Contents
Advances in Pharmacological Sciences
Volume 2011 (2011), Article ID 254619, 7 pages
http://dx.doi.org/10.1155/2011/254619
Review Article

The Pharmacology of Acute Lung Injury in Sepsis

Division of Critical Care, Cincinnati Children's Hospital Medical Center, MLC 2005, Cincinnati, OH 45229-3039, USA

Received 18 February 2011; Accepted 3 May 2011

Academic Editor: William J. Wheeler

Copyright © 2011 Brian Michael Varisco. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Phua, J. R. Badia, N. K. J. Adhikari et al., “Has mortality from acute respiratory distress syndrome decreased over time? A systematic review,” American Journal of Respiratory and Critical Care Medicine, vol. 179, no. 3, pp. 220–227, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. S. E. Erickson, G. S. Martin, J. L. Davis, M. A. Matthay, and M. D. Eisner, “Recent trends in acute lung injury mortality: 1996–2005,” Critical Care Medicine, vol. 37, no. 5, pp. 1574–1579, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. A. G. Randolph, “Management of acute lung injury and acute respiratory distress syndrome in children,” Critical Care Medicine, vol. 37, no. 8, pp. 2448–2454, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. P. Dahlem, W. M. C. van Aalderen, and A. P. Bos, “Pediatric acute lung injury,” Paediatric Respiratory Reviews, vol. 8, no. 4, pp. 348–362, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. C. Rossi, B. Simini, L. Brazzi et al., “Variable costs of ICU patients: a multicenter prospective study,” Intensive Care Medicine, vol. 32, no. 4, pp. 545–552, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. G. R. Bernard, A. Artigas, K. L. Brigham et al., “Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination,” Intensive Care Medicine, vol. 20, no. 3, pp. 225–232, 1994. View at Scopus
  7. H. R. Flori, D. V. Glidden, G. W. Rutherford, and M. A. Matthay, “Pediatric acute lung injury: prospective evaluation of risk factors associated with mortality,” American Journal of Respiratory and Critical Care Medicine, vol. 171, no. 9, pp. 995–1001, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. G. Nash, F. D. Foley, and P. C. Langlinais, “Pulmonary interstitial edema and hyaline membranes in adult burn patients. Electron microscopic observations,” Human Pathology, vol. 5, no. 2, pp. 149–160, 1974. View at Scopus
  9. P. C. Pratt, R. T. Vollmer, and J. D. Shelburne, “Pulmonary morphology in a multihospital collaborative extracorporeal membrane oxygenation project. I. Light microscopy,” American Journal of Pathology, vol. 95, no. 1, pp. 191–214, 1979. View at Scopus
  10. R. Marshall, G. Bellingan, and G. Laurent, “The acute respiratory distress syndrome: fibrosis in the fast lane,” Thorax, vol. 53, no. 10, pp. 815–817, 1998. View at Scopus
  11. M. Sarker, J. Rose, M. McDonald, M. R. Morrow, and V. Booth, “Modifications to surfactant protein B structure and Lipid interactions under respiratory distress conditions: consequences of tryptophan oxidation,” Biochemistry, vol. 50, no. 1, pp. 25–36, 2011. View at Publisher · View at Google Scholar · View at PubMed
  12. J. A. Zasadzinski, P. C. Stenger, I. Shieh, and P. Dhar, “Overcoming rapid inactivation of lung surfactant: analogies between competitive adsorption and colloid stability,” Biochimica et Biophysica Acta, vol. 1798, no. 4, pp. 801–828, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. P. Markart, C. Ruppert, M. Wygrecka et al., “Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids,” Thorax, vol. 62, no. 7, pp. 588–594, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. G. Zhou, L. A. Dada, M. Wu et al., “Hypoxia-induced alveolar epithelial-mesenchymal transition requires mitochondrial ROS and hypoxia-inducible factor 1,” American Journal of Physiology, vol. 297, no. 6, pp. L1120–L1130, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. D. Kang, T. Nakayama, M. Togashi et al., “Two forms of diffuse alveolar damage in the lungs of patients with acute respiratory distress syndrome,” Human Pathology, vol. 40, no. 11, pp. 1618–1627, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. L. Synenki, N. S. Chandel, G. R. S. Budinger et al., “Bronchoalveolar lavage fluid from patients with acute lung injury/acute respiratory distress syndrome induces myofibroblast differentiation,” Critical Care Medicine, vol. 35, no. 3, pp. 842–848, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. Y. Y. Sanders, P. Kumbla, and J. S. Hagood, “Enhanced myofibroblastic differentiation and survival in thy-1(-) lung fibroblasts,” American Journal of Respiratory Cell and Molecular Biology, vol. 36, no. 2, pp. 226–235, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. C. Quesnel, L. Nardelli, P. Piednoir et al., “Alveolar fibroblasts in acute lung injury: biological behaviour and clinical relevance,” European Respiratory Journal, vol. 35, no. 6, pp. 1312–1321, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. J. I. Peters, R. C. Bell, T. J. Prihoda, G. Harris, C. Andrews, and W. G. Johanson, “Clinical determinants of abnormalities in pulmonary functions in survivors of the adult respiratory distress syndrome,” American Review of Respiratory Disease, vol. 139, no. 5, pp. 1163–1168, 1989. View at Scopus
  20. “American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS),” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 2, pp. 646–664, 2000.
  21. A. Esan, D. R. Hess, S. Raoof, L. George, and C. N. Sessler, “Severe hypoxemic respiratory failure—part 1—ventilatory strategies,” Chest, vol. 137, no. 5, pp. 1203–1216, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. R. G. Brower, M. A. Matthay, A. Morris, D. Schoenfeld, B. T. Thompson, and A. Wheeler, “Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome,” New England Journal of Medicine, vol. 342, no. 18, pp. 1301–1308, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. R. G. Brower, P. N. Lanken, N. MacIntyre et al., “Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome,” New England Journal of Medicine, vol. 351, no. 4, pp. 327–336, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. S. Derdak, S. Mehta, T. E. Stewart et al., “High-frequency oscillatory ventilation for acute respiratory distress syndrome in adults: a randomized, controlled trial,” American Journal of Respiratory and Critical Care Medicine, vol. 166, no. 6, pp. 801–808, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. C. W. Bollen, G. T. van Well, T. Sherry et al., “High frequency oscillatory ventilation compared with conventional mechanical ventilation in adult respiratory distress syndrome: a randomized controlled trial [ISRCTN24242669],” Critical Care, vol. 9, no. 4, pp. R430–R439, 2005. View at Scopus
  26. T. Varpula, P. Valta, R. Niemi, O. Takkunen, M. Hynynen, and V. Pettilä, “Airway pressure release ventilation as a primary ventilatory mode in acute respiratory distress syndrome,” Acta Anaesthesiologica Scandinavica, vol. 48, no. 6, pp. 722–731, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. W. Verbrugghe and P. G. Jorens, “Neurally adjusted ventilatory assist (NAVA): a new ventilatory tool or a ventilatory toy?” Respiratory Care, vol. 56, no. 3, pp. 327–335, 2011. View at Publisher · View at Google Scholar · View at PubMed
  28. M. O. Meade, D. J. Cook, G. H. Guyatt et al., “Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial,” Journal of the American Medical Association, vol. 299, no. 6, pp. 637–645, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. M. A. Q. Curley, P. L. Hibberd, L. D. Fineman et al., “Effect of prone positioning on clinical outcomes in children with acute lung injury: a randomized controlled trial,” Journal of the American Medical Association, vol. 294, no. 2, pp. 229–237, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. L. G. Gattinoni, G. Tognoni, A. Pesenti et al., “Effect of prone positioning on the survival of patients with acute respiratory failure,” New England Journal of Medicine, vol. 345, no. 8, pp. 568–573, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. H. Humphrey, J. Hall, I. Sznajder, M. Silverstein, and L. Wood, “Improved survival in ARDS patients associated with a reduction in pulmonary capillary wedge pressure,” Chest, vol. 97, no. 5, pp. 1176–1180, 1990. View at Scopus
  32. H. P. Wiedemann, A. P. Wheeler, G. R. Bernard et al., “Comparison of two fluid-management strategies in acute lung injury,” New England Journal of Medicine, vol. 354, no. 24, pp. 2564–2575, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. G. S. Martin, M. Moss, A. P. Wheeler, M. Mealer, J. A. Morris, and G. R. Bernard, “A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury,” Critical Care Medicine, vol. 33, no. 8, pp. 1681–1687, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. G. S. Martin, R. J. Mangialardi, A. P. Wheeler, W. D. Dupont, J. A. Morris, and G. R. Bernard, “Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury,” Critical Care Medicine, vol. 30, no. 10, pp. 2175–2182, 2002. View at Scopus
  35. M. A. Matthay and S. Idell, “Update on acute lung injury and critical care medicine 2009,” American journal of respiratory and critical care medicine, vol. 181, no. 10, pp. 1027–1032, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. L. A. Zabrocki, T. V. Brogan, K. D. Statler, W. B. Poss, M. D. Rollins, and S. L. Bratton, “Extracorporeal membrane oxygenation for pediatric respiratory failure: survival and predictors of mortality,” Critical Care Medicine, vol. 39, no. 2, pp. 364–370, 2011. View at Publisher · View at Google Scholar · View at PubMed
  37. W. M. Zapol, M. T. Snider, and J. D. Hill, “Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study,” Journal of the American Medical Association, vol. 242, no. 20, pp. 2193–2196, 1979. View at Publisher · View at Google Scholar · View at Scopus
  38. A. H. Morris, C. J. Wallace, R. L. Menlove et al., “Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for Adult Respiratory Distress Syndrome,” American Journal of Respiratory and Critical Care Medicine, vol. 149, no. 2 I, pp. 295–305, 1994. View at Scopus
  39. G. J. Peek, M. Mugford, R. Tiruvoipati et al., “Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial,” The Lancet, vol. 374, no. 9698, pp. 1351–1363, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. S. G. Norfolk, C. L. Hollingsworth, C. R. Wolfe et al., “Rescue therapy in adult and pediatric patients with pH1N1 influenza infection: a tertiary center intensive care unit experience from April to October 2009,” Critical Care Medicine, vol. 38, no. 11, pp. 2103–2107, 2010. View at Publisher · View at Google Scholar · View at PubMed
  41. B. Floerchinger, A. Philipp, M. Foltan et al., “Switch from venoarterial extracorporeal membrane oxygenation to arteriovenous pumpless extracorporeal lung assist,” Annals of Thoracic Surgery, vol. 89, no. 1, pp. 125–131, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. S. L. Stirling, J. J. Cordingley, D. N. Hunter et al., “Extracorporeal carbon dioxide removal to “protect” the lung,” Thorax, vol. 64, no. 8, pp. 726–727, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. M. Confalonieri, R. Urbino, A. Potena et al., “Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study,” American Journal of Respiratory and Critical Care Medicine, vol. 171, no. 3, pp. 242–248, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. D. Annane, V. Sébille, and E. Bellissant, “Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome,” Critical Care Medicine, vol. 34, no. 1, pp. 22–30, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. G. U. Meduri, E. Golden, A. X. Freire et al., “Methylprednisolone infusion in early severe ards: results of a randomized controlled trial,” Chest, vol. 131, no. 4, pp. 954–963, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. G. U. Meduri, A. S. Headley, E. Golden et al., “Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial,” Journal of the American Medical Association, vol. 280, no. 2, pp. 159–165, 1998. View at Publisher · View at Google Scholar · View at Scopus
  47. K. P. Steinberg, L. D. Hudson, R. B. Goodman et al., “Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome,” New England Journal of Medicine, vol. 354, no. 16, pp. 1671–1684, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. G. U. Meduri, P. E. Marik, G. P. Chrousos et al., “Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature,” Intensive Care Medicine, vol. 34, no. 1, pp. 61–69, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. V. Sidhaye, J. D. Hoffert, and L. S. King, “cAMP has distinct acute and chronic effects on aquaporin-5 in lung epithelial cells,” Journal of Biological Chemistry, vol. 280, no. 5, pp. 3590–3596, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. S. Manocha, A. C. Gordon, E. Salehifar, H. Groshaus, K. R. Walley, and J. A. Russell, “Inhaled beta-2 agonist salbutamol and acute lung injury: an association with improvement in acute lung injury,” Critical Care, vol. 10, no. 1, article R12, 2006. View at Publisher · View at Google Scholar · View at PubMed
  51. Y. Wang, H. G. Folkesson, C. Jayr, L. B. Ware, and M. A. Matthay, “Alveolar epithelial fluid transport can be simultaneously upregulated by both KGF and β-agonist therapy,” Journal of Applied Physiology, vol. 87, no. 5, pp. 1852–1860, 1999. View at Scopus
  52. T. Sakuma, G. Okaniwa, T. Nakada, T. Nishimura, S. Fujimura, and M. A. Matthay, “Alveolar fluid clearance in the resected human lung,” American Journal of Respiratory and Critical Care Medicine, vol. 150, no. 2, pp. 305–310, 1994. View at Scopus
  53. G. M. Mutlu, V. Dumasius, J. Burhop et al., “Upregulation of alveolar epithelial active Na+ transport is dependent on β-adrenergic receptor signaling,” Circulation Research, vol. 94, no. 8, pp. 1091–1100, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. G. D. Perkins, D. F. McAuley, D. R. Thickett, and F. Gao, “The β-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial,” American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 3, pp. 281–287, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. C. A. Reising, A. Chendrasekhar, P. L. Wall, N. F. Paradise, G. A. Timberlake, and D. W. Moorman, “Continuous dose furosemide as a therapeutic approach to acute respiratory distress syndrome (ARDS),” Journal of Surgical Research, vol. 82, no. 1, pp. 56–60, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. A. Yuengsrigul, T. W. Chin, and E. Nussbaum, “Immunosuppressive and cytotoxic effects of furosemide on human peripheral blood mononuclear cells,” Annals of Allergy, Asthma and Immunology, vol. 83, no. 6 I, pp. 559–566, 1999. View at Scopus
  57. S. Deem, C. M. Lee, and J. R. Curtis, “Acquired neuromuscular disorders in the intensive care unit,” American Journal of Respiratory and Critical Care Medicine, vol. 168, no. 7, pp. 735–739, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. L. Papazian, J.-M. Forel, A. Gacouin et al., “Neuromuscular blockers in early acute respiratory distress syndrome,” New England Journal of Medicine, vol. 363, no. 12, pp. 1107–1116, 2010. View at Publisher · View at Google Scholar · View at PubMed
  59. R. F. Soll, “Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD000511, 2000.
  60. R. F. Soll, “Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD001079, 2000.
  61. J. Wirbelauer and C. P. Speer, “The role of surfactant treatment in preterm infants and term newborns with acute respiratory distress syndrome,” Journal of Perinatology, vol. 29, no. 2, pp. S18–S22, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. R. G. Spragg, J. F. Lewis, H. D. Walmrath et al., “Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome,” New England Journal of Medicine, vol. 351, no. 9, pp. 884–947, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. T. J. Gregory, K. P. Steinberg, R. Spragg et al., “Bovine surfactant therapy for patients with acute respiratory distress syndrome,” American Journal of Respiratory and Critical Care Medicine, vol. 155, no. 4, pp. 1309–1315, 1997. View at Scopus
  64. A. Anzueto, R. P. Baughman, K. K. Guntupalli et al., “Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome,” New England Journal of Medicine, vol. 334, no. 22, pp. 1417–1421, 1996. View at Publisher · View at Google Scholar · View at PubMed
  65. J. Kesecioglu, R. Beale, T. E. Stewart et al., “Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome,” American Journal of Respiratory and Critical Care Medicine, vol. 180, no. 10, pp. 989–994, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. V. P. Carnielli, L. J. I. Zimmermann, A. Hamvas, and P. E. Cogo, “Pulmonary surfactant kinetics of the newborn infant: novel insights from studies with stable isotopes,” Journal of Perinatology, vol. 29, no. 2, supplement, pp. S29–S37, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  67. G. Verlato, P. E. Cogo, M. Balzani et al., “Surfactant status in preterm neonates recovering from respiratory distress syndrome,” Pediatrics, vol. 122, no. 1, pp. 102–108, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  68. E. Baraldi and M. Filippone, “Chronic lung disease after premature birth,” New England Journal of Medicine, vol. 357, no. 19, pp. 1946–1955, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. J. E. Balinotti, C. J. Tiller, C. J. Llapur et al., “Growth of the lung parenchyma early in life,” American Journal of Respiratory and Critical Care Medicine, vol. 179, no. 2, pp. 134–137, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  70. J. B. West, Respiratory Physiology: The Essentials, Lippincott Williams & Wilkins, Baltimore, Md, USA, 7th edition, 2005.
  71. D. F. Willson, J. H. Jiao, L. A. Bauman et al., “Calf's lung surfactant extract in acute hypoxemic respiratory failure in children,” Critical Care Medicine, vol. 24, no. 8, pp. 1316–1322, 1996. View at Scopus
  72. D. F. Willson, N. J. Thomas, B. P. Markovitz et al., “Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial,” Journal of the American Medical Association, vol. 293, no. 4, pp. 470–476, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  73. T. Curstedt and J. Johansson, “Different effects of surfactant proteins B and C—implications for development of synthetic surfactants,” Neonatology, vol. 97, no. 4, pp. 367–372, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  74. H. L. Halliday, “Surfactants: past, present and future,” Journal of Perinatology, vol. 28, no. 1, supplement, pp. S47–S56, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  75. D. F. Willson and N. J. Thomas, “Surfactant composition and biophysical properties are important in clinical studies,” American Journal of Respiratory and Critical Care Medicine, vol. 181, no. 7, p. 762, 2010.
  76. S. H. Abman, “Pulmonary hypertension in children: a historical overview,” Pediatric Critical Care Medicine, vol. 11, no. 2, supplement, pp. S4–S9, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  77. A. Afshari, J. Brok, A. M. Møller, and J. Wetterslev, “Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) and acute lung injury in children and adults,” Cochrane Database of Systematic Reviews, vol. 7, Article ID CD002787, 2010.
  78. P. Singer, M. Theilla, H. Fisher, L. Gibstein, E. Grozovski, and J. Cohen, “Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury,” Critical Care Medicine, vol. 34, no. 4, pp. 1033–1038, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  79. A. Pontes-Arruda, S. DeMichele, A. Seth, and P. Singer, “The use of an inflammation-modulating diet in patients with acute lung injury or acute respiratory distress syndrome: a meta-analysis of outcome data,” Journal of Parenteral and Enteral Nutrition, vol. 32, no. 6, pp. 596–605, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  80. M. R. Wolfson and T. H. Shaffer, “Pulmonary applications of perfluorochemical liquids: ventilation and beyond,” Paediatric Respiratory Reviews, vol. 6, no. 2, pp. 117–127, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  81. C. L. Leach, J. S. Greenspan, S. D. Rubenstein et al., “Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome,” New England Journal of Medicine, vol. 335, no. 11, pp. 761–767, 1996. View at Publisher · View at Google Scholar · View at PubMed
  82. P. G. Gauger, T. Pranikoff, R. J. Schreiner, F. W. Moler, and R. B. Hirschl, “Initial experience with partial liquid ventilation in pediatric patients with the acute respiratory distress syndrome,” Critical Care Medicine, vol. 24, no. 1, pp. 16–22, 1996. View at Scopus
  83. J. S. Greenspan, M. R. Wolfson, S. D. Rubenstein, and T. H. Shaffer, “Liquid ventilation of human preterm neonates,” Journal of Pediatrics, vol. 117, no. 1 I, pp. 106–111, 1990. View at Publisher · View at Google Scholar · View at Scopus
  84. J. S. Greenspan, M. R. Wolfson, S. D. Rubenstein, and T. H. Shaffer, “Liquid ventilation of preterm baby,” Lancet, vol. 2, no. 8671, p. 1095, 1989. View at Scopus
  85. M. W. Davies, K. R. Dunster, K. Wilson, and P. B. Colditz, “Perfluorocarbon dosing when starting partial liquid ventilation: haemodynamics and cerebral blood flow in preterm lambs,” Neonatology, vol. 97, no. 2, pp. 144–153, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  86. A. F. Shorr, G. R. Bernard, J. F. Dhainaut et al., “Protein C concentrations in severe sepsis: an early directional change in plasma levels predicts outcome,” Critical Care, vol. 10, no. 3, article R92, 2006. View at Publisher · View at Google Scholar · View at PubMed
  87. G. R. Bernard, J. L. Vincent, P. F. Laterre et al., “Efficacy and safety of recombinant human activated protein C for severe sepsis,” New England Journal of Medicine, vol. 344, no. 10, pp. 699–709, 2001. View at Publisher · View at Google Scholar · View at Scopus
  88. N. A. Maniatis, E. Letsiou, S. E. Orfanos et al., “Inhaled activated protein C protects mice from ventilator-induced lung injury,” Critical Care, vol. 14, article R70, 2010. View at Publisher · View at Google Scholar · View at PubMed
  89. J. M. Hare, J. H. Traverse, T. D. Henry et al., “A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (Prochymal) after acute myocardial infarction,” Journal of the American College of Cardiology, vol. 54, no. 24, pp. 2277–2286, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  90. S. H. J. Mei, J. J. Haitsma, C. C. Dos Santos et al., “Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis,” American Journal of Respiratory and Critical Care Medicine, vol. 182, no. 8, pp. 1047–1057, 2010. View at Publisher · View at Google Scholar · View at PubMed
  91. S. Bruno, B. Bussolati, C. Grange et al., “Isolation and characterization of resident mesenchymal stem cells in human glomeruli,” Stem Cells and Development, vol. 18, no. 6, pp. 867–879, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  92. M. Rojas, J. Xu, C. R. Woods et al., “Bone marrow-derived mesenchymal stem cells in repair of the injured lung,” American Journal of Respiratory Cell and Molecular Biology, vol. 33, no. 2, pp. 145–152, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  93. L. A. Ortiz, F. Gambelli, C. McBride et al., “Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8407–8411, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  94. N. Gupta, X. Su, B. Popov, W. L. Jae, V. Serikov, and M. A. Matthay, “Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice,” Journal of Immunology, vol. 179, no. 3, pp. 1855–1863, 2007. View at Scopus
  95. D. S. Krause, N. D. Theise, M. I. Collector et al., “Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell,” Cell, vol. 105, no. 3, pp. 369–377, 2001. View at Publisher · View at Google Scholar · View at Scopus